Ctexli
Payments companies reported to CMS as associated with Ctexli. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ctexli, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ctexli
These are the largest totals companies reported as associated with Ctexli. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Yasushi Kisanuki | Gahanna, OH | Neurology (Psychiatry & Neurology) | $47,746.92 |
| Paul Hillman | Houston, TX | Clinical Genetics (M.D.) | $36,712.01 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $24,478.06 |
| Vikram Prakash | Orlando, FL | Neurology With Special Qualifications In Child Neurology | $14,070.20 |
| Robert Steiner | Madison, WI | Clinical Genetics (M.D.) | $10,550.83 |
| Luca Marsili | Cincinnati, OH | Neurology (Psychiatry & Neurology) | $3,153.70 |
| Eliot Brinton | Salt Lake City, UT | Endocrinology, Diabetes & Metabolism | $2,780.00 |
| Lauren Thompson | Charleston, SC | Medical Biochemical Genetics | $2,780.00 |
| Jennifer Rossen | Chicago, IL | Pediatric Ophthalmology and Strabismus Specialist | $2,395.00 |
| Ta Chen Chang | Miami, FL | Ophthalmology | $1,625.00 |
Prescribed Ctexli?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.